| Literature DB >> 27062204 |
J A Trubiano1,2, A C Cheng3,4,5, T M Korman6, C Roder7,8, A Campbell9, M L A May10, C C Blyth9,11,12, J K Ferguson13,14,15, T K Blackmore16, T V Riley17,18, E Athan7,19.
Abstract
The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.Entities:
Keywords: Clostridium difficile; faecal microbiota transplant (FMT); fidaxomicin; metronidazole; treatment; vancomycin
Mesh：
Year: 2016 PMID： 27062204 DOI： 10.1111/imj.13027
Source DB: PubMed Journal: Intern Med J ISSN： 1444-0903 Impact factor: 2.048